Table 1 Patient characteristics at the first evaluation of Cr-eGFR
From: Assessment of the renal function of patients with anorexia nervosa
Parameter | N | Median (min–max), or n (%) |
|---|---|---|
Sex, female, n (%) | 39 | 38 (97.4) |
Age (years) | 39 | 13 (7–16) |
Height-SDS | 39 | − 1.0 (− 3.0–1.3) |
BMI-SDS | 39 | − 2.0 (− 7.1–1.0) |
Degree of obesity | 39 | − 22.8 (− 47.1–13.3) |
Type of AN, AN-R, n (%) | 39 | 37 (94.9) |
Duration of illness (months) | 25 | 13 (1–75) |
BT (℃) | 8 | 36.3 (35.0–37.0) |
HR (bpm) | 34 | 61 (40–100) |
SBP (mmHg) | 32 | 94 (62–126) |
DBP (mmHg) | 32 | 58 (38–90) |
Alb (g/dL) | 33 | 4.7 (3.9–5.5) |
Pre-Alb (mg/dL) | 28 | 21 (12–38) |
Cr-eGFR (mL/min/1.73 m2) | 39 | 96.2 (59.9–126.1) |
CysC-eGFR (mL/min/1.73 m2) | 5 | 136.8 (127.4–149.9) |
Na (mEq/L) | 37 | 140 (135–147) |
K (mEq/L) | 37 | 4.2 (3.6–5.3) |
Cl (mEq/L) | 37 | 105 (98–111) |
Ca (mg/dL) | 37 | 9.4 (8.5–10.2) |
P (mg/dL) | 36 | 3.8 (2.5–5.0) |
Ht (%) | 39 | 39.4 (33.9–47.3) |
UA (mg/dL) | 21 | 4.3 (2.6–6.0) |
BUN (mg/dL) | 39 | 16.5 (7.9–42.7) |
Usg | 29 | 1.022 (1.003–1.037) |
FT3 (pg/mL) | 25 | 1.52 (0.4–3.1) |
FT4 (ng/dL) | 31 | 1.04 (0.62–1.47) |
TSH (μU/mL) | 31 | 1.08 (0.15–5.58) |
IGF1 (ng/mL) | 14 | 64.2 (6.3–284) |
ACTH (pg/mL) | 3 | 38.9 (25.8–40.0) |
Cortisol (μU/dL) | 11 | 17.8 (8.7–29.8) |
LH (mIU/mL) | 23 | 0.3 (0.2–88.9) |
FSH (mIU/mL) | 23 | 1.0 (0.3–21.9) |
E2 (pg/mL) | 22 | 9.9 (5.0–298.1) |